Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Accounts Receivable: ₫0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company Accounts Receivable?

Pharmedic Pharmaceutical Medicinal Joint Stock Company HSTC:PMC -3.62% Accounts Receivable is ₫0.00 Mil as of . 20.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Pharmedic Pharmaceutical Medicinal Joint Stock Company's accounts receivables for the quarter that ended in . 20 was ₫0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Pharmedic Pharmaceutical Medicinal Joint Stock Company's Net-Net Working Capital per share for the quarter that ended in . 20 was ₫N/A.


Pharmedic Pharmaceutical Medicinal Joint Stock Company Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Pharmedic Pharmaceutical Medicinal Joint Stock Company's accounts receivable are only considered to be worth 75% of book value:

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Net-Net Working Capital Per Share for the quarter that ended in . 20 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(+0.75 * +0.5 * -N/A
--)/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Pharmedic Pharmaceutical Medicinal Joint Stock Company Accounts Receivable Related Terms


Pharmedic Pharmaceutical Medicinal Joint Stock Company Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Accounts Receivable Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
Accounts Receivable

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
Accounts Receivable

Pharmedic Pharmaceutical Medicinal Joint Stock Company Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of ₫0.00 Mil mean?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a Accounts Receivable of ₫0.00 Mil as of . 20. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company's Accounts Receivable too high?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's current Accounts Receivable is ₫0.00 Mil.
How does Pharmedic Pharmaceutical Medicinal Joint Stock Company's Accounts Receivable compare to IMNPQ?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's Accounts Receivable of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Drug Manufacturers company?
A good Accounts Receivable depends on the Drug Manufacturers industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors. Pharmedic Pharmaceutical Medicinal Joint Stock Company's current Accounts Receivable is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company stock overvalued right now?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a current Accounts Receivable of ₫0.00 Mil. The current Accounts Receivable is ₫0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC), the current Accounts Receivable is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Business Description

Address 367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, cosmetics, medical supplies, and other products in the health sector. The company's products include Farzincol Bottle, Farzincol Syrup, Sibemag, Vitamin C 50, Vitamin PP 500, Vitamin PP 50, Nacofar, Cooldrop, Inhaler, Povidine 10% 90ml, Povidine 4% 500, Povidine 10% 8ml, and Povidine 4% 800.